Cargando…
Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial
Atopic dermatitis is a chronic inflammatory skin disease that affects the growth and development of children. The prevalence of atopic dermatitis has been continually increasing, and this has also been accompanied by rising socioeconomic costs. Interest has been growing in alternative medicine as a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726431/ https://www.ncbi.nlm.nih.gov/pubmed/33324225 http://dx.doi.org/10.3389/fphar.2020.597885 |
_version_ | 1783620886241214464 |
---|---|
author | Lee, Ju Hyun Jo, Eun Heui Jung, Jee Youn Kim, Young-Eun Son, Mi-Ju Kang, Su Jin Yang, Geum Jin Shim, Yu Hwa Park, Min Cheol |
author_facet | Lee, Ju Hyun Jo, Eun Heui Jung, Jee Youn Kim, Young-Eun Son, Mi-Ju Kang, Su Jin Yang, Geum Jin Shim, Yu Hwa Park, Min Cheol |
author_sort | Lee, Ju Hyun |
collection | PubMed |
description | Atopic dermatitis is a chronic inflammatory skin disease that affects the growth and development of children. The prevalence of atopic dermatitis has been continually increasing, and this has also been accompanied by rising socioeconomic costs. Interest has been growing in alternative medicine as a means of alleviating the burden of atopic dermatitis. This was a single-center, double-blinded, randomized, placebo-controlled investigator-led clinical trial including 60 atopic dermatitis patients. The participants were classified into an experimental group (30 persons) and a control group (30 persons), who were administered, respectively, socheongryong-tang or a placebo for 4 weeks. After 4 weeks of treatment, the participants visited the trial center again and assess their efficacy and safety. The researchers performed statistical comparisons of the changes in the SCORAD Index, amount and frequency of ointment use, and height and weight to assess the efficacy. To assess the safety, diagnostic tests and vital sign checks were performed at each visit, and the presence or absence of adverse events was observed. As a result, the frequency and the amount of steroid ointment application in both groups increased, but the experimental group showed less tendency (p = 0.081). Results of analyzing the children in the experimental group in relation to growth showed a significantly greater height growth than the control group (p < 0.05). In addition, all study participants did not show any remarkable abnormal signs in the safety evaluation. In conclusion, compared to the control group, the experimental group, who took socheongryong-tang showed a tendency to be less dependent on steroid ointment and statistically significant increase in height. |
format | Online Article Text |
id | pubmed-7726431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77264312020-12-14 Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Lee, Ju Hyun Jo, Eun Heui Jung, Jee Youn Kim, Young-Eun Son, Mi-Ju Kang, Su Jin Yang, Geum Jin Shim, Yu Hwa Park, Min Cheol Front Pharmacol Pharmacology Atopic dermatitis is a chronic inflammatory skin disease that affects the growth and development of children. The prevalence of atopic dermatitis has been continually increasing, and this has also been accompanied by rising socioeconomic costs. Interest has been growing in alternative medicine as a means of alleviating the burden of atopic dermatitis. This was a single-center, double-blinded, randomized, placebo-controlled investigator-led clinical trial including 60 atopic dermatitis patients. The participants were classified into an experimental group (30 persons) and a control group (30 persons), who were administered, respectively, socheongryong-tang or a placebo for 4 weeks. After 4 weeks of treatment, the participants visited the trial center again and assess their efficacy and safety. The researchers performed statistical comparisons of the changes in the SCORAD Index, amount and frequency of ointment use, and height and weight to assess the efficacy. To assess the safety, diagnostic tests and vital sign checks were performed at each visit, and the presence or absence of adverse events was observed. As a result, the frequency and the amount of steroid ointment application in both groups increased, but the experimental group showed less tendency (p = 0.081). Results of analyzing the children in the experimental group in relation to growth showed a significantly greater height growth than the control group (p < 0.05). In addition, all study participants did not show any remarkable abnormal signs in the safety evaluation. In conclusion, compared to the control group, the experimental group, who took socheongryong-tang showed a tendency to be less dependent on steroid ointment and statistically significant increase in height. Frontiers Media S.A. 2020-11-26 /pmc/articles/PMC7726431/ /pubmed/33324225 http://dx.doi.org/10.3389/fphar.2020.597885 Text en Copyright © 2020 Lee, Jo, Jung, Kim, Son, Kang, Yang, Shim and Park http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Lee, Ju Hyun Jo, Eun Heui Jung, Jee Youn Kim, Young-Eun Son, Mi-Ju Kang, Su Jin Yang, Geum Jin Shim, Yu Hwa Park, Min Cheol Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial |
title | Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial |
title_full | Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial |
title_fullStr | Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial |
title_full_unstemmed | Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial |
title_short | Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial |
title_sort | efficacy and safety of socheongryong-tang among atopic dermatitis patients with respiratory disorders: a double-blinded, randomized, placebo-controlled clinical trial |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726431/ https://www.ncbi.nlm.nih.gov/pubmed/33324225 http://dx.doi.org/10.3389/fphar.2020.597885 |
work_keys_str_mv | AT leejuhyun efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT joeunheui efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT jungjeeyoun efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT kimyoungeun efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT sonmiju efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT kangsujin efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT yanggeumjin efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT shimyuhwa efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial AT parkmincheol efficacyandsafetyofsocheongryongtangamongatopicdermatitispatientswithrespiratorydisordersadoubleblindedrandomizedplacebocontrolledclinicaltrial |